MYOMO, INC. Segments Disclosure
Note 14 — Segment Reporting and Major Customers
Segment Reporting
ACS 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about products, business segments, and major customers in financial statements. The Company conducts its business in one operating segment, and sells products in one family, which are versions of the MyoPro. While the Company has several sales channels and operates in different geographies, the Chief Executive Officer, who is the Company's chief operating decision-maker, and is responsible for allocating resources and assessing the performance of the Company, manages the Company's business on a consolidated basis, focusing on revenue, gross margin, certain operating expenses, loss from operations, other expenses (income), Income Tax, and Net loss. The Chief Executive Officer reviews the consolidated balance sheet with relation to consolidated Assets. The Chief Executive Officer does not review any additional or more disaggregated level.
For the years ended December 31, |
|
2025 |
|
|
2024 |
|
||
Revenue |
|
|
40,928,042 |
|
|
|
32,551,199 |
|
|
|
|
|
|
|
|
||
Cost of revenue |
|
|
14,039,718 |
|
|
|
9,365,856 |
|
Gross profit |
|
|
26,888,324 |
|
|
|
23,185,343 |
|
Gross margin |
|
|
65.7 |
% |
|
|
71.2 |
% |
Operating expenses: |
|
|
|
|
|
|
||
Payroll and benefits expense |
|
|
28,820,190 |
|
|
|
22,642,489 |
|
Advertising |
|
|
8,032,258 |
|
|
|
3,484,824 |
|
All other segment operating expenses |
|
|
10,783,001 |
|
|
|
6,701,412 |
|
Payroll and benefits expense in cost of revenue |
|
|
(6,345,278 |
) |
|
|
(3,436,684 |
) |
|
|
|
41,290,171 |
|
|
|
29,392,041 |
|
Loss from operations |
|
$ |
(14,401,847 |
) |
|
$ |
(6,206,698 |
) |
Other expense (income) |
|
|
667,505 |
|
|
|
(388,586 |
) |
Income tax expense |
|
|
504,532 |
|
|
|
365,617 |
|
Net Loss |
|
$ |
(15,573,884 |
) |
|
$ |
(6,183,729 |
) |
All other segment operating expenses: include Product Development, Software Expense, Travel and Entertainment, Outside Services, Consultants, and Legal Fees.
Major Customers
For the years ended December 31, 2025 and 2024, there were no customers which accounted for more than 10% of revenues. For the year ended December 31, 2025, patients with Medicare Part B insurance represented 54% of revenues. For the year ended December 31, 2024, patients with Medicare Part B insurance and a U.S insurance payer represented 49% and 18% respectively, of revenues.
For the year ended December 31, 2025, CMS, U.S. commercial insurer and its affiliates, and an O&P customer, accounted for approximately 25%, 16%, and 12% of accounts receivable, respectively. For the year ended December 31, 2024, CMS and a U.S. commercial insurer and its affiliates, accounted for approximately 36% and 19% of accounts receivable.
For the year ended December 31, 2025 and 2024, approximately 20% and 25% of the Company's total revenues were derived from patients with Medicare Advantage insurance plans, respectively
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 9, 2026 | Showing above |
| 2024 | Mar 10, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.